MIRA INFORM REPORT

 

 

Report No. :

312546

Report Date :

20.03.2015

 

IDENTIFICATION DETAILS

 

Name :

QUINTILES RESEARCH (INDIA) PRIVATE LIMITED

 

 

Registered Office :

B 101-106, Shapath IV, Opposite Karnavati Club, Sarkhej, Gandhinagar Road, Ahmedabad -380051, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

21.11.2002

 

 

Com. Reg. No.:

04-074076

 

 

Capital Investment / Paid-up Capital :

Rs.8.131 Million

 

 

CIN No.:

[Company Identification No.]

U73100GJ2002PTC074076

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACQ0935H

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

The Company is principally engaged in undertaking clinical research activities on behalf of pharmaceutical companies on a contractual basis in India. The services include study design, protocol development, monitoring of the research and related activities.

 

 

No. of Employees :

Information declined by the management.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (53)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist

 

 

Comments :

Subject is a well-established company having fine track.

 

The rating takes into consideration decent profit margin and strong liquidity position backed by debt free balance sheet of the company.

 

Trade relations are fair. Business is active. Payment terms are reported to be regular and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DENIED

 

Management non-co-operative (91-79-66303300)

 

 

LOCATIONS

 

Registered Office :

B 101-106, Shapath IV, Opposite Karnavati Club, Sarkhej, Gandhinagar Road, Ahmedabad -380051, Gujarat, India

Tel. No.:

91-79-66303300

Fax No.:

91-79-66303366

E-Mail :

Soumyo.ghosh@quintiles.com

Website :

www.quintiles.com

 

 

Head Office :

2nd Floor, Etamin Block, Prestige Technology Park II, Sarjpur, Marathalli Outer Ring Road, Bangalore – 560103, Karnataka, India

 

 

 

 

DIRECTORS

 

As on 30.09.2014

 

Name :

Mr. Anand Joshi

Designation :

Director

Address :

24, Drive In Tenaments, Thaltej Road, Thaltej, Ahmedabad – 380054, Gujarat, India

Date of Birth/Age :

11.02.1970

Date of Appointment :

03.02.2004

DIN No.:

00021890

PAN No.:

AAPPJ8312H

Passport No.:

A9636181

Other Directorship :

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U73100GJ2002PTC074076

QUINTILES RESEARCH (INDIA) PRIVATE LIMITED

Director

03/02/2004

03/02/2004

-

Active

NO

2

U72300GJ2001PTC040151

QUINTILES DATA PROCESSING CENTRE (INDIA) PRIVATE LIMITED

Director

13/02/2004

13/02/2004

-

Amalgamated

NO

3

U72200KA2007PTC042174

Cenduit (India) Services Private Limited

Director

20/09/2010

20/09/2010

23/04/2012

Active

NO

4

U73100GJ2002PTC041630

QUINTILES TECHNOLOGIES (INDIA) PRIVATE LIMITED

Director

01/05/2013

01/05/2013

-

Amalgamated

NO

 

 

Name :

Suneela Milind Thatte

Designation :

Director

Address :

B 204, Sadguru Complex, 1AB, Behind Vageshwari Temple, Goregaon East, Mumbai – 400063, Maharashtra, India

Date of Birth/Age :

13.12.1969

Date of Appointment :

01.04.2009

DIN No.:

02621328

PAN No.:

AADPT6076E

Passport No.:

G1951527

 

 

Name :

Mr. Hemant Rehani

Designation :

Director

Address :

Villa 28, Chaithanya Armadale, Whitefield, Bangalore – 560066, Karnataka, India

Date of Birth/Age :

30.01.1972

Date of Appointment :

23.12.2011

DIN No.:

05154646

PAN No.:

AAOPR1187P

Passport No.:

E0749722

 

Name :

Mr. Soumyo Ghosh

Designation :

Director

Address :

B-1/008, Genesis, Near Suncity, Appartments, Sarjapur Outer Ring Road Junction, Bangalore – 560034, Karnataka, India

Date of Birth/Age :

24.10.1969

Date of Appointment :

23.04.2013

DIN No.:

06563813

PAN No.:

AAOPG0440Q

Passport No.:

Z2226539

Other Directorship :

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U72300GJ2001PTC040151

QUINTILES DATA PROCESSING CENTRE (INDIA) PRIVATE LIMITED

Director

23/04/2013

23/04/2013

-

Amalgamated

NO

2

U73100GJ2002PTC041630

QUINTILES TECHNOLOGIES (INDIA) PRIVATE LIMITED

Director

23/04/2013

23/04/2013

-

Amalgamated

NO

3

U73100GJ2002PTC074076

QUINTILES RESEARCH (INDIA) PRIVATE LIMITED

Director

23/04/2013

23/04/2013

-

Active

NO

4

U73100TG2009FTC064239

Quintiles Phase One Clinical Trials India Private Limited

Alternate director

06/05/2013

06/05/2013

-

Active

NO

 

 

Name :

Mr. Jacob Parambi Sebasitan

Designation :

Director

Address :

2 H, Belveder Court 6, Spencer Road, Frazer Tow, Bangalore – 560005, Karnataka, India

Date of Birth/Age :

25.10.1963

Date of Appointment :

30.09.2014

DIN No.:

06882662

PAN No.:

AALPJ0019M

Passport No.:

Z2024274

Other Directorship :

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U73100GJ2002PTC074076

QUINTILES RESEARCH (INDIA) PRIVATE LIMITED

Director

30/09/2014

09/06/2014

-

Active

NO

2

U72300GJ2001PTC040151

QUINTILES DATA PROCESSING CENTRE (INDIA) PRIVATE LIMITED

Director

30/09/2014

09/06/2014

-

Amalgamated

NO

3

U73100GJ2002PTC041630

QUINTILES TECHNOLOGIES (INDIA) PRIVATE LIMITED

Director

30/09/2014

09/06/2014

-

Amalgamated

NO

 

 

MAJOR SHAREHOLDERS

 

As on 30.09.2014

 

Names of Shareholders

 

No. of Shares

Quintiles Mauritius Holdings Inc., Mauritius

 

803130

Quintiles Transnational Corporation, USA

 

10000

Total

 

813130

 

As on 30.09.2014

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

The Company is principally engaged in undertaking clinical research activities on behalf of pharmaceutical companies on a contractual basis in India. The services include study design, protocol development, monitoring of the research and related activities.

 

 

Products :

Not Available

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

PRODUCTION STATUS = NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

 

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

No. of Employees :

Information declined by the management.

 

 

Bankers :

Banker Name

Not Divulged

Branch Address

Not Divulged

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

 

 

 

Auditors :

 

Name :

Price Waterhouse and Company

Chartered Accountants

Address :

252 Veer Sarvarkar Marg, Shivaji Park , Dadar(West), Mumbai – 400028, Maharashtra, India

PAN No.:

AAAFP8828M

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Holding Company :

Quintiles Mauritius Holding Inc., Mauritius

 

 

Ultimate Holding Company :

Quintiles Transnational Corporation, USA

 

 

Fellow Subsidiary Company :

  • Quintiles Pacific Inc., USA
  • Quintiles Limited, UK
  • Quintiles Clindepharm Private Limited, South Africa
  • Quintiles Bloemfontein, South Africa
  • Quintiles Medical Development Shanghai
  • Quintiles Clindata Private Limited, South Africa
  • Quintiles Private Limited, Australia
  • Quintiles Latin America, Inc., USA
  • Quintiles Medical Development (Shanghai) Company, Shanghai
  • Quintiles East Asia Pte Limited, Singapore
  • Quintiles B.V., Netherland
  • Quintiles (Thailand ) Company Limited, Thailand
  • Quintiles S.l, Spain
  • Quintiles AB, Sweden
  • Quintiles Transnational Japan K. K., Japan
  • Quintiles East Asia Pte Limited, Vietnam
  • Quintiles Malaysia SDN BHD, Malaysia
  • Quintiles Ireland Limited, Ireland
  • Quintiles Egypt LLC, Egypt
  • Quintiles Phase One Services, Inc., United States
  • Quintiles Taiwan, Province of China
  • Outcome Sciences INC., USA
  • Quintiles Medical Research and Development (Beijing) Limited, China

 

 

 

CAPITAL STRUCTURE

 

As on 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2000000

Equity Shares

Rs.10/- each

Rs.20.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

813130

Equity Shares

Rs.10/- each

Rs.8.131 Million

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2014

31.03.2013

31.03.2012

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

8.131

8.131

8.131

(b) Reserves & Surplus

750.364

607.630

502.206

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

758.495

615.761

510.337

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

18.781

25.603

24.623

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

18.781

25.603

24.623

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

36.278

22.472

8.753

(c) Other current liabilities

130.684

73.046

72.335

(d) Short-term provisions

13.881

6.160

35.132

Total Current Liabilities (4)

180.843

101.678

116.220

 

 

 

 

TOTAL

958.119

743.042

651.180

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

84.809

96.393

70.962

(ii) Intangible Assets

2.612

2.538

3.155

(iii) Capital work-in-progress

14.264

4.831

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

23.441

18.377

8.888

(d)  Long-term Loan and Advances

51.537

57.773

30.601

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

176.663

179.912

113.606

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

0.000

0.000

0.000

(c) Trade receivables

7.301

84.875

83.905

(d) Cash and cash equivalents

554.036

200.062

154.601

(e) Short-term loans and advances

218.213

268.105

283.115

(f) Other current assets

1.906

10.088

15.953

Total Current Assets

781.456

563.130

537.574

 

 

 

 

TOTAL

958.119

743.042

651.180

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

Income

1004.871

1032.279

972.083

 

Other Income

29.159

27.533

31.769

 

TOTAL

1034.030

1059.812

1003.852

 

 

 

 

 

Less

EXPENSES

 845.288

 891.354

 828.224

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

188.742

168.458

175.628

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

30.837

29.516

32.511

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

157.905

138.942

143.117

 

 

 

 

 

Less

TAX

15.172

33.518

0.327

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

142.733

105.424

142.790

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD 

605.670

500.246

357.456

 

 

 

 

 

 

Balance Carried to the B/S

748.403

605.670

500.246

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

175.54

129.65

175.61

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/Sales)

(%)

14.20

10.21

14.69

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

17.16

19.30

22.28

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.21

0.23

0.28

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

4.32

5.54

4.63

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

8.131

8.131

8.131

Reserves & Surplus

502.206

607.630

750.364

Net worth

510.337

615.761

758.495

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

972.083

1032.279

1004.871

 

 

6.192

(2.655)

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

972.083

1032.279

1004.871

Profit

142.790

105.424

142.733

 

14.69%

10.21%

14.20%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

No

24]

Banking facility details

No

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

LITIGATION DETAILS:

 

HIGH COURT OF GUJARAT

TAX APPEAL No. 2005 of 2010

 

Status : PENDING

( Converted from : ST/2544/2010 )

CCIN No : 001092201002005

Last Listing Date:

18/09/2012

 

Coram

HONOURABLE MR.JUSTICE AKIL KURESHI

HONOURABLE MS.JUSTICE HARSHA DEVANI

 

 

S.NO.

Name of the Petitioner

Advocate On Record

1

COMMISSIONER OF SERVICE TAX, AHMEDABAD

MR KALPESH N SHASTRI for: Appellant(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

S.NO.

Name of the Respondant

Advocate On Record

1

M/S QUINTILES RESEARCH (INDIA) PVT LTD

MRS SWATI SOPARKAR for :Opponent(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

 

 

Presented On

: 06/09/2010

Registered On

: 06/09/2010

Bench Category

: DIVISION BENCH

District

: AHMEDABAD

Case Originated From

: THROUGH HIS/HER/THEIR ADVOCATE

Listed

: 125 times

StageName

: FOR FINAL HEARING

 

Classification

DB - OJ - TAX APPEAL - CENTRAL EXCISE ACT, 1944 - UNDER SECTION 35G

Act

CENTRAL EXCISES AND SALT ACT, 1944

Office Details

 

S. No.

Filing Date

Document Name

Advocate Name

Court Fee on Document

Document Details

1

15/08/2010

VAKALATNAMA

MR KALPESH N SHASTRI ADVOCATE
for PETITIONER(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

-

MR KALPESH N SHASTRI:1

2

15/08/2010

VAKALATNAMA

MRS SWATI SOPARKAR ADVOCATE
for RESPONDENT(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

-

MRS SWATI SOPARKAR:1

3

06/09/2010

CERTIFIED COPY

MR KALPESH N SHASTRI ADVOCATE
for PETITIONER(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

4

MR KALPESH N SHASTRI:1

4

06/09/2010

MEMO OF APPEAL/PETITION/SUIT

MR KALPESH N SHASTRI ADVOCATE
for PETITIONER(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

50

MR KALPESH N SHASTRI:1

5

14/06/2011

VAKALATNAMA

MRS SWATI SOPARKAR ADVOCATE
for RESPONDENT(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

5

MRS SWATI SOPARKAR:1

Applications

 

S. No.

Case Detail

Status Name

Disposal Date

Action/Coram

1

CIVIL APPLICATION/395/2010

DISPOSED

07/04/2011

ANY OTHER MODE @ ADM.STAGE

HONOURABLE MR.JUSTICE AKIL KURESHI

HONOURABLE MS JUSTICE SONIA GOKANI

Court Proceedings

 

S. No.

Notified Date

Court Code

Board Sr. No.

Stage

Action

Coram

1

07/04/2011

10

-

BOARD NO. I-A

FIXED RULE / ADMIT

HONOURABLE MR.JUSTICE AKIL KURESHI

HONOURABLE MS JUSTICE SONIA GOKANI

2

09/07/2012

3

-

FOR FINAL HEARING

NEXT DATE

HONOURABLE THE ACTING CHIEF JUSTICE MR. VIJAY MANOHAR SAHAI

HONOURABLE MR.JUSTICE N.V.ANJARIA

3

18/09/2012

9

-

FOR FINAL HEARING

FIXED RULE / ADMIT

HONOURABLE MR.JUSTICE AKIL KURESHI

HONOURABLE MS.JUSTICE HARSHA DEVANI

Available Orders

 

S. No.

Case Details

Judge Name

Order Date

CAV

Judgement

Questions

Transferred

1

TAX APPEAL/2005/2010

HONOURABLE MR.JUSTICE AKIL KURESHI

HONOURABLE MS JUSTICE SONIA GOKANI

07/04/2011

N

ORDER

-

Y

2

TAX APPEAL/1735/2010

HONOURABLE THE ACTING CHIEF JUSTICE MR. VIJAY MANOHAR SAHAI

HONOURABLE MR.JUSTICE N.V.ANJARIA

19/06/2012

N

ORDER

-

Y

 

 

OPERATIONS OF THE COMPANY

 

During year under consideration, the company has earned revenue of Rs. 1004.000 Million which is 2.65% lower than last year. The company has also earned net profit after tax of Rs. 142.700 Million which is higher by 35.38% as compared to last year. The Directors expect good growth over the coming years.

 

 

BACKGROUND OF THE COMPANY

 

Quintiles Research (India) Private Limited was incorporated on November 21, 2002 and is a subsidiary of Quintiles Mauritius Holdings (QMH), the ultimate holding company being Quintiles Transnational Corporation, USA. The Company is principally engaged in undertaking clinical research activities on behalf of pharmaceutical companies on a contractual basis in India. The services include study design, protocol development, monitoring of the research and related activities. The Company has the approval from the Office of the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India vide its letter dated May 30, 2003.

 

 

INDEX OF CHARGES: NO CHARGES EXIST FOR THE COMPANY

 

 

FIXED ASSETS

 

  • Office Equipments
  • Computers
  • Furniture and Fixtures
  • Vehicles

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.42

UK Pound

1

Rs.92.99

Euro

1

Rs.67.28

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Analysis Done by :

SUM

 

 

Report Prepared by :

PNM


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILITY 

1~10

7

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

7

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

---

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

 

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

53

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.